Vivo Capital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001674712 · Show all filings

Period: Q3 2017 (← Previous) (Next →)

Filing Date: Nov 13, 2017

Total Value: $495M (100.0% shares, 0.0% debt)

Holdings (29)

— Biohaven Pharmaceutical Holding Company Ltd 14.9%

Value $73.89M Shares 1,976,818 Est. Cost $37.38 Unrealized —

ACRS Aclaris Therapeutics 14.9%

Value $73.78M Shares 2,858,569 Est. Cost $19.11 Unrealized +40.3%

ASND Ascendis Pharma 12.9%

Value $64.05M Shares 1,766,832 Est. Cost $17.51 Unrealized —

— Nabriva Therapeutics PLC 6.7%

Value $33.37M Shares 4,074,190 Est. Cost $8.19 Unrealized —

— Kala Pharmaceuticals Inc. 5.3%

Value $26.47M Shares 1,158,911 Est. Cost $22.84 Unrealized —

— Verona Pharma Plc 4.6%

Value $22.92M Shares 1,492,951 Est. Cost $13.61 Unrealized —

— Strongbridge Biopharma plc 4.1%

Value $20.44M Shares 2,962,645 Est. Cost $2.40 Unrealized —

— Selecta Biosciences, Inc. 4.1%

Value $20.43M Shares 1,119,189 Est. Cost $19.86 Unrealized —

CDXS Codexis, Inc. 4.1%

Value $20.32M Shares 3,054,825 Est. Cost $3.85 Unrealized +43.6%

— Eiger BioPharmaceuticals 4.0%

Value $19.66M Shares 1,787,091 Est. Cost $16.42 Unrealized —

— Aimmune Therapeutics, Inc. 3.9%

Value $19.26M Shares 776,813 Est. Cost $10.99 Unrealized —

— Advanced Accelerator Applications S.A. 3.4%

Value $16.85M Shares 249,241 Est. Cost $35.30 Unrealized —

— Kadmon Holdings, Inc. 2.3%

Value $11.17M Shares 3,333,333 Est. Cost $3.35 Unrealized —

— Amyris 1.8%

Value $9.045M Shares 2,826,711 Est. Cost $3.20 Unrealized —

ZLAB Zai Lab 1.8%

Value $8.775M Shares 325,000 Est. Cost $27.00 Unrealized —

— Soleno Therapeutics, Inc. 1.5%

Value $7.642M Shares 14,695,264 Est. Cost $0.52 Unrealized —

AUPH Aurinia Pharmaceuticals Inc. 1.5%

Value $7.607M Shares 1,213,290 Est. Cost $5.62 Unrealized +12.2%

— Agile Therapeutics, Inc. 1.4%

Value $6.752M Shares 1,513,975 Est. Cost $6.21 Unrealized —

RGNX Regenxbio Inc. 1.1%

Value $5.417M Shares 164,403 Est. Cost $12.80 Unrealized +75.8%

— Foamix Pharmaceuticals Ltd. 1.0%

Value $4.745M Shares 855,000 Est. Cost $9.26 Unrealized —

— Trevena, Inc. 0.9%

Value $4.406M Shares 1,728,000 Est. Cost $7.67 Unrealized —

— BioPharmX Corporation 0.8%

Value $4.032M Shares 14,096,338 Est. Cost $0.38 Unrealized —

— Sierra Oncology, Inc 0.8%

Value $3.779M Shares 2,438,270 Est. Cost $1.55 Unrealized —

CRSP CRISPR Therapeutics AG 0.5%

Value $2.66M Shares 148,878 Est. Cost $18.69 Unrealized -3.0%

— ReVance Therapeutics, Inc. 0.4%

Value $2.132M Shares 77,373 Est. Cost $24.38 Unrealized —

— Akari Therapeutics Plc 0.4%

Value $2.124M Shares 345,850 Est. Cost $14.00 Unrealized —

KALV KalVista Pharmaceuticals, Inc. 0.4%

Value $2.021M Shares 300,325 Est. Cost $7.13 Unrealized 0.0%

— Sunesis Pharmaceuticals, Inc. 0.2%

Value $970K Shares 500,000 Est. Cost $3.62 Unrealized —

— Soleno Therapeutics, Inc. (W) 0.0%

Value $112K Shares 943,858 Est. Cost $0.12 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Biohaven Pharmaceutical Holding Company Ltd	1,976,818	$73.89M	14.9%	$37.38	—	Common	G11196105
ACRS	Aclaris Therapeutics	2,858,569	$73.78M	14.9%	$19.11	+40.3%	Common	00461U105
ASND	Ascendis Pharma	1,766,832	$64.05M	12.9%	$17.51	—	ADR	04351P101
—	Nabriva Therapeutics PLC	4,074,190	$33.37M	6.7%	$8.19	—	SHS	G63637105
—	Kala Pharmaceuticals Inc.	1,158,911	$26.47M	5.3%	$22.84	—	Common	483119103
—	Verona Pharma Plc	1,492,951	$22.92M	4.6%	$13.61	—	ADS	925050106
—	Strongbridge Biopharma plc	2,962,645	$20.44M	4.1%	$2.40	—	Ordinary Shares	G85347105
—	Selecta Biosciences, Inc.	1,119,189	$20.43M	4.1%	$19.86	—	Common	816212104
CDXS	Codexis, Inc.	3,054,825	$20.32M	4.1%	$3.85	+43.6%	Common	192005106
—	Eiger BioPharmaceuticals	1,787,091	$19.66M	4.0%	$16.42	—	Common	28249U105
—	Aimmune Therapeutics, Inc.	776,813	$19.26M	3.9%	$10.99	—	Common	00900T107
—	Advanced Accelerator Applications S.A.	249,241	$16.85M	3.4%	$35.30	—	ADS	00790T100
—	Kadmon Holdings, Inc.	3,333,333	$11.17M	2.3%	$3.35	—	Common	48283N106
—	Amyris	2,826,711	$9.045M	1.8%	$3.20	—	Common	03236M200
ZLAB	Zai Lab	325,000	$8.775M	1.8%	$27.00	—	ADR	98887Q104
—	Soleno Therapeutics, Inc.	14,695,264	$7.642M	1.5%	$0.52	—	Common	834203101
AUPH	Aurinia Pharmaceuticals Inc.	1,213,290	$7.607M	1.5%	$5.62	+12.2%	Common	05156V102
—	Agile Therapeutics, Inc.	1,513,975	$6.752M	1.4%	$6.21	—	Common	00847L100
RGNX	Regenxbio Inc.	164,403	$5.417M	1.1%	$12.80	+75.8%	Common	75901B107
—	Foamix Pharmaceuticals Ltd.	855,000	$4.745M	1.0%	$9.26	—	SHS	M46135105
—	Trevena, Inc.	1,728,000	$4.406M	0.9%	$7.67	—	Common	89532E109
—	BioPharmX Corporation	14,096,338	$4.032M	0.8%	$0.38	—	Common	09072X101
—	Sierra Oncology, Inc	2,438,270	$3.779M	0.8%	$1.55	—	Common	82640U107
CRSP	CRISPR Therapeutics AG	148,878	$2.66M	0.5%	$18.69	-3.0%	NAMEN AKT	H17182108
—	ReVance Therapeutics, Inc.	77,373	$2.132M	0.4%	$24.38	—	Common	761330109
—	Akari Therapeutics Plc	345,850	$2.124M	0.4%	$14.00	—	ADR	00972G108
KALV	KalVista Pharmaceuticals, Inc.	300,325	$2.021M	0.4%	$7.13	0.0%	Common	483497103
—	Sunesis Pharmaceuticals, Inc.	500,000	$970K	0.2%	$3.62	—	Common	867328700
—	Soleno Therapeutics, Inc. (W)	943,858	$112K	0.0%	$0.12	—	Warrant	834203119